German biotech firm BioNTech and US drugmaker Pfizer Monday reported additional data from their experimental COVID-19 vaccine that showed it was safe and induced an immune response in patients. BioNtech's US shares gained 12 percent, while Pfizer's stock rose 3.6 percent in early trading....